Delivery Order SPE2DB20D9354-SPE2DB25FX7U2
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $8,622.72 by the Defense Logistics Agency (DLA) on August 18, 2025. The delivery order, which carries a firm fixed-price structure with an ultimate completion date of August 19, 2025, is for 120 capsules of Xtandi 40 mg, an oncology medication used in cancer treatment. This award was issued without a set-aside designation, demonstrating the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency (DLA) on August 14, 2025. The contract calls for the delivery of Xtandi 80 mg tablets (60-count supply), an oncology medication used in prostate cancer treatment. This delivery order carries an ultimate completion date of August 15, 2025, and was awarded without a set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $17,245.40 by the Defense Logistics Agency (DLA) on August 1, 2025. The contract, which carries no set-aside designation, calls for the delivery of 120 units of Xtandi 40 mg capsules, an oncology medication used in the treatment of prostate cancer. The delivery order is scheduled for completion by August 4, 2025, with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,683.02 by the Defense Logistics Agency (DLA) on August 18, 2025. The contract calls for the delivery of Xtandi 80 mg tablets (60-count units), an oncology medication used in cancer treatment, with an ultimate completion date of August 19, 2025. This delivery order was issued without a set-aside designation, allowing the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,169.59 by the Defense Logistics Agency (DLA) on July 22, 2025. The contract, which carries no set-aside designation, calls for the delivery of 60 tablets of Xtandi 80 mg, an oncology medication used in cancer treatment. This delivery order represents one of many pharmaceutical supply orders issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,622.72 by the Defense Logistics Agency's Medical Supply Chain on September 18, 2025, with an ultimate completion date of September 19, 2025. The delivery order is for 120 capsules of Xtandi 40 mg, an oncology medication used in the treatment of advanced prostate cancer. This award was issued without a set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,311.35 by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Xtandi 40 mg capsules (120-count units). The delivery order carries an ultimate completion date of August 1, 2025, and was issued without set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,311.35 by the Defense Logistics Agency (DLA) on August 26, 2025. The contract calls for the supply of Xtandi 40 mg capsules (120-count units), an oncology medication used in cancer treatment. This delivery order operates under a firm fixed-price structure with no set-aside designation, with an ultimate completion date of August 27, 2025....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $8.6K for 120 capsules of Xtandi 40 mg, an oncology medication. The award was issued on August 1, 2025, with an ultimate completion date of August 4, 2025, under a firm fixed-price contract type with no set-aside designation. The contract is being funded by the Medical Supply Chain, a defense-oriented federal agency, with performance...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $8,339.18 from the Defense Logistics Agency (DLA) on September 12, 2025. The contract calls for the delivery of Xtandi 40 mg tablets in a quantity of 120 units, with an ultimate completion date of September 15, 2025. This delivery order was issued without a set-aside designation, allowing the company to compete on an...
- SPE2DB20D9354Indefinite Delivery Contract
- SPE2DB20D9354-SPE2DB25FX7U2Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,622.72 by the Defense Logistics Agency (DLA) on June 2, 2025, with an ultimate completion date of June 3, 2025. The contract, numbered 4568429678, involves the delivery of 120 capsules of Xtandi 40 mg, an oncology medication used in the treatment of prostate cancer. This delivery order was issued without set-aside designation and is to be performed at the contractor's facility in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This master contract enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables, to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's established position as a trusted federal pharmaceutical supplier is evidenced by its consistent award of delivery orders across diverse medical product categories, reinforcing its role as a critical supplier within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 6/2/25 |